Want to join the conversation?
Matthew Harrison of Morgan Stanley asks when $VRTX will be able to recognize revenues in France. Chief Medical Officer Jeffrey Chodakewitz said that $VRTX is providing access to Orkambi and it is being paid for that drug in France. He added that from a GAAP perspective, the company is not able to report it and anticipates reporting that in 2017.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.